ProQR Therapeutics (PRQR) News Today

→ Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad)

$1.90

-0.10 (-5.00%)

(As of 04/17/2024 ET)

Source

Source	Headline
	ProQR Therapeutics (NASDAQ:PRQR) Shares Pass Above Fifty Day Moving Average of $2.16 americanbankingnews.com - April 16 at 3:56 AM
	ProQR Therapeutics N.V. (PRQR) finance.yahoo.com - April 8 at 10:59 AM
	ProQR Therapeutics (NASDAQ:PRQR) Given Consensus Recommendation of "Buy" by Analysts marketbeat.com - March 29 at 2:14 AM
	ProQR Therapeutics (NASDAQ:PRQR) Given "Buy" Rating at HC Wainwright marketbeat.com - March 18 at 4:33 PM
	Chardan Capital Boosts ProQR Therapeutics (NASDAQ:PRQR) Price Target to $2.50 marketbeat.com - March 18 at 4:33 PM
	ProQR Therapeutics (NASDAQ:PRQR) Short Interest Update marketbeat.com - March 15 at 8:19 PM
	Buy Rating Affirmed: ProQR’s Axiomer Platform Shows Promising Potential in CNS and Metabolic Disorders markets.businessinsider.com - March 14 at 7:10 PM
	Buy Rating Affirmed for ProQR on Strong Financials and Promising RNA Editing Platform markets.businessinsider.com - March 14 at 9:09 AM
	ProQR Therapeutics Full Year 2023 Earnings: Misses Expectations finance.yahoo.com - March 14 at 9:09 AM
	ProQR Announces Year End 2023 Operating and Financial Results globenewswire.com - March 13 at 7:00 AM
	ProQR Therapeutics (NASDAQ:PRQR) Upgraded by StockNews.com to Buy marketbeat.com - March 11 at 11:15 PM
	PRQR Mar 2024 2.500 call finance.yahoo.com - February 18 at 1:10 PM
	ProQR Therapeutics N.V. wsj.com - February 16 at 8:41 AM
	ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing finance.yahoo.com - February 15 at 8:39 AM
	ProQR Therapeutics (NASDAQ:PRQR) Given Consensus Recommendation of "Buy" by Brokerages marketbeat.com - February 8 at 1:34 AM
	StockNews.com Downgrades ProQR Therapeutics (NASDAQ:PRQR) to Hold marketbeat.com - February 2 at 1:19 AM
	4 Biotech Stocks With Massive Buy Potential stocknews.com - January 30 at 12:06 PM
	StockNews.com Upgrades ProQR Therapeutics (NASDAQ:PRQR) to Buy marketbeat.com - January 25 at 1:25 AM
	ProQR Therapeutics N.V.: ProQR Highlights New Platform Data from Presentation on Axiomer RNA Editing Technology at Deaminet 2024 finanznachrichten.de - January 19 at 10:54 AM
	ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024 finance.yahoo.com - January 19 at 10:54 AM
	While institutions invested in ProQR Therapeutics N.V. (NASDAQ:PRQR) benefited from last week's 12% gain, individual investors stood to gain the most finance.yahoo.com - January 15 at 10:48 AM
	ProQR Therapeutics (NASDAQ:PRQR) Sees Large Decrease in Short Interest marketbeat.com - January 13 at 7:21 PM
	Buy Rating Affirmed for ProQR on Strategic Partnership and Promising Axiomer RNA Editing Platform markets.businessinsider.com - January 6 at 9:56 AM
	ProQR Therapeutics N.V.: ProQR and Rett Syndrome Research Trust Join Forces with Axiomer RNA Editing Collaboration finanznachrichten.de - January 5 at 2:10 PM
	ProQR Therapeutics Stock (NASDAQ:PRQR) Dividends: History, Yield and Dates benzinga.com - January 5 at 9:09 AM
	ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration finance.yahoo.com - January 5 at 9:09 AM
	ProQR Therapeutics (NASDAQ:PRQR) Stock Rating Upgraded by StockNews.com marketbeat.com - January 4 at 10:13 PM
	Is ProQR (PRQR) Stock a Solid Choice Right Now? finance.yahoo.com - December 28 at 3:51 PM
	ProQR’s Strategic Divestiture and Strong Financial Outlook Justify Buy Rating markets.businessinsider.com - December 9 at 7:34 AM
	ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets finance.yahoo.com - December 8 at 10:21 AM
	ProQR Therapeutics NV PRQR morningstar.com - November 21 at 10:48 PM
	Positive Report for ProQR (PRQR) from Chardan Capital markets.businessinsider.com - November 9 at 10:51 AM
	Buy Rating for ProQR Therapeutics: Robust RNA-Editing Patent Portfolio, Promising Preclinical Candidates, and Strong Financial Position markets.businessinsider.com - November 9 at 10:51 AM
	Chardan Capital Upgrades ProQR Therapeutics N.V (PRQR) msn.com - November 8 at 11:17 PM
	ProQR Announces Third Quarter 2023 Operating and Financial Results finance.yahoo.com - November 7 at 7:12 AM
	ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing finance.yahoo.com - November 6 at 8:56 AM
	ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference finance.yahoo.com - September 28 at 12:50 PM
	ProQR Therapeutics Provides Update on Ophthalmic Assets finance.yahoo.com - September 27 at 10:14 AM
	ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference finance.yahoo.com - September 7 at 10:48 AM
	Short Interest in ProQR Therapeutics (NASDAQ:PRQR) Drops By 16.4% marketbeat.com - August 28 at 3:21 AM
	ProQR Therapeutics (NASDAQ:PRQR) Receives Average Rating of "Moderate Buy" from Brokerages marketbeat.com - August 17 at 2:20 AM
	ProQR Therapeutics (NASDAQ:PRQR) Sees Significant Growth in Short Interest marketbeat.com - August 11 at 7:17 AM
	Q3 2023 Earnings Forecast for ProQR Therapeutics Issued By HC Wainwright (NASDAQ:PRQR) marketbeat.com - August 9 at 8:18 AM
	ProQR Therapeutics N.V.'s (NASDAQ:PRQR) top owners are retail investors with 50% stake, while 31% is held by institutions finance.yahoo.com - August 8 at 8:43 AM
	Chardan Capital Reiterates ProQR Therapeutics N.V (PRQR) Neutral Recommendation msn.com - August 4 at 10:38 PM
	4 Analysts Have This to Say About ProQR Therapeutics markets.businessinsider.com - August 4 at 5:38 PM
	ProQR Therapeutics (NASDAQ:PRQR) Receives Neutral Rating from Chardan Capital marketbeat.com - August 4 at 11:01 AM
	ProQR Announces Second Quarter 2023 Operating and Financial Results uk.finance.yahoo.com - August 3 at 7:39 AM
	ProQR Therapeutics (NASDAQ:PRQR) Lowered to "Hold" at StockNews.com marketbeat.com - August 3 at 3:46 AM
	ProQR Therapeutics and Laboratoires Théa Announce Agreement for Théa to Acquire ProQR's Sepofarsen and Ultevursen Ophthalmic Assets technews.tmcnet.com - August 2 at 10:50 AM

Get ProQR Therapeutics News Delivered to You Automatically

AI “wealth window” is closing soon! (Ad)

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

PRQR Media Mentions By Week

PRQR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PRQR
News Sentiment
▼
1.05

0.35
▲
Average
Medical
News Sentiment

PRQR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PRQR Articles
This Week
▼
1

1
▲
PRQR Articles
Average Week

Get ProQR Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:PRQR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ProQR Therapeutics (PRQR) News Today

PRQR Media Mentions By Week

PRQR Media Sentiment

PRQR News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info